BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11036260)

  • 21. Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats.
    Wiley JL; O'connell MM; Tokarz ME; Wright MJ
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1097-105. PubMed ID: 17172531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
    Hershkowitz M; Szechtman H
    Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comments on the APA position statement on psychoactive substance abuse and dependence: update on marijuana and cocaine.
    Am J Psychiatry; 1988 Feb; 145(2):273-4. PubMed ID: 2829634
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioral effects of self-administered cocaine: responding maintained alternately by cocaine and electric shock in squirrel monkeys.
    Spealman RD; Kelleher RT
    J Pharmacol Exp Ther; 1979 Aug; 210(2):206-14. PubMed ID: 110922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.
    Chait LD; Zacny JP
    Psychopharmacology (Berl); 1992; 107(2-3):255-62. PubMed ID: 1319601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
    Wiebelhaus JM; Grim TW; Owens RA; Lazenka MF; Sim-Selley LJ; Abdullah RA; Niphakis MJ; Vann RE; Cravatt BF; Wiley JL; Negus SS; Lichtman AH
    J Pharmacol Exp Ther; 2015 Feb; 352(2):195-207. PubMed ID: 25398241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.
    Assaf F; Fishbein M; Gafni M; Keren O; Sarne Y
    Behav Brain Res; 2011 Jun; 220(1):194-201. PubMed ID: 21315768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marijuana effects on sensitivity to reinforcement in humans.
    Lane SD; Cherek DR
    Neuropsychopharmacology; 2002 Apr; 26(4):520-9. PubMed ID: 11927176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of estradiol on cocaine self-administration and cocaine discrimination by female rhesus monkeys.
    Mello NK; Negus SS; Knudson IM; Kelly M; Mendelson JH
    Neuropsychopharmacology; 2008 Mar; 33(4):783-95. PubMed ID: 17507915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):894-902. PubMed ID: 17505018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of cannabinoids.
    McGilveray IJ
    Pain Res Manag; 2005; 10 Suppl A():15A-22A. PubMed ID: 16237477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats.
    Belluzzi JD; Wang R; Leslie FM
    Neuropsychopharmacology; 2005 Apr; 30(4):705-12. PubMed ID: 15496937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are choice and self-administration of marijuana related to delta 9-THC content?
    Kelly TH; Foltin RW; Emurian CS; Fischman MW
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):74-82. PubMed ID: 9234042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.
    Tanda G
    Psychopharmacology (Berl); 2016 May; 233(10):1845-66. PubMed ID: 27026633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High rates of midazolam self-administration in squirrel monkeys.
    Munzar P; Yasar S; Redhi GH; Justinova Z; Goldberg SR
    Behav Pharmacol; 2001 Jul; 12(4):257-65. PubMed ID: 11548111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of dronabinol for cannabis dependence: two case reports and review.
    Levin FR; Kleber HD
    Am J Addict; 2008; 17(2):161-4. PubMed ID: 18393061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relating Observed Psychoactive Effects to the Plasma Concentrations of Delta-9-Tetrahydrocannabinol and Its Active Metabolite: An Effect-Compartment Modeling Approach.
    Awasthi R; An G; Donovan MD; Boles Ponto LL
    J Pharm Sci; 2018 Feb; 107(2):745-755. PubMed ID: 28942005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rabbit behavioral model of marijuana psychoactivity in humans.
    Consroe P; Fish BS
    Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent behavior at high rates maintained by intravenous self-administration of nicotine.
    Goldberg SR; Spealman RD; Goldberg DM
    Science; 1981 Oct; 214(4520):573-5. PubMed ID: 7291998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reinforcing and adverse observable effects of nicotine and minor tobacco alkaloids in squirrel monkeys.
    Burke EL; Desai RI
    Drug Alcohol Depend; 2024 May; 258():111280. PubMed ID: 38614019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.